Gene · 2195
Papers4,590
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,590
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Effect of ten-eleven translocation methylcytosine dioxygenase 2 gene mutations on the secondary myelofibrosis of JAK2V617F positive myeloproliferative neoplasms patients]. | Zhonghua Yi Xue Za Zhi | 2025 | 39828579 | PubTator, text mining | PubMed |
| Targeting YAP/TAZ-TEAD signaling as a therapeutic approach in head and neck squamous cell carcinoma. | Cancer Lett | 2025 | 39826667 | PubTator, text mining | PubMed |
| De novo Membranous Nephropathy in Renal Allografts is Associated With Protocadherin FAT1. | Kidney Int Rep | 2025 | 39810776 | PubTator, text mining | PubMed |
| FAT1 knockdown enhances the CSC properties of HNSCC through p-CaMKII-mediated inactivation of the IFN pathway. | Int J Biol Sci | 2025 | 39781458 | PubTator, text mining | PubMed |
| FAT1 alterations contribute to chromosomal instability in cancer cells. | Nat Cell Biol | 2025 | 39779945 | PubTator, text mining | PubMed |
| Recent advances in the role of atypical cadherin FAT1 in tumorigenesis (Review). | Oncol Lett | 2025 | 39776648 | PubTator, text mining | PubMed |
| TRACERx analysis identifies a role for FAT1 in regulating chromosomal instability and whole-genome doubling via Hippo signalling. | Nat Cell Biol | 2025 | 39738653 | PubTator, text mining | PubMed |
| Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR Predict Shorter Survival in Penile Squamous Cell Carcinoma. | Mod Pathol | 2025 | 39694330 | PubTator, text mining | PubMed |
| Inhibiting autophagy enhances idarubicin chemosensitivity and induces immune escape in FAT1-low-expressing AML cells. | Int Immunopharmacol | 2025 | 39615108 | PubTator, text mining | PubMed |
| Creeping Fat-Derived Free Fatty Acids Induce Hyperplasia of Intestinal Muscularis Propria Muscle Cells: A Novel Link Between Fat and Intestinal Stricture Formation in Crohn's Disease. | Gastroenterology | 2025 | 39522890 | PubTator, text mining | PubMed |
| Endometrial carcinomas with ambiguous histology often harbor TP53 mutations. | Virchows Arch | 2025 | 39235515 | PubTator, text mining | PubMed |
| Precision therapy targeting CAMK2 to overcome resistance to EGFR inhibitors in FAT1 -mutated oral squamous cell carcinoma. | Chin Med J (Engl) | 2025 | 39227322 | PubTator, text mining | PubMed |
| Scaffold hopping approaches for the exploration of herbicidally active compounds inhibiting Acyl-ACP Thioesterase. | Pest Manag Sci | 2025 | 39158367 | PubTator, text mining | PubMed |
| Decoding pathology: the role of computational pathology in research and diagnostics. | Pflugers Arch | 2025 | 39095655 | PubTator, text mining | PubMed |
| Imaging of the superficial white matter in health and disease. | Imaging Neurosci (Camb) | 2024 | 40800408 | PubTator, text mining | PubMed |
| FAT1 weighted MRI: Diffusion meets anatomical imaging and application in thalamic surgery for tremor. | Imaging Neurosci (Camb) | 2024 | 40800267 | PubTator, text mining | PubMed |
| A proteomic atlas of glypican-3 interacting partners: Identification of alpha-fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer. | Proteoglycan Res | 2024 | 39822733 | PubTator, text mining | PubMed |
| A Critical Review on microRNAs as Prognostic Biomarkers in Laryngeal Carcinoma. | Int J Mol Sci | 2024 | 39769234 | PubTator, text mining | PubMed |
| Discover Mutational Differences Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma and Search for More Effective Biomarkers for Immunotherapy. | Cancer Manag Res | 2024 | 39678041 | PubTator, text mining | PubMed |
Emulsions stabilized by pea protein-rich ingredients as an alternative to dairy proteins for food sustainability: Unveiling the key role of pea endogenous lipids in the surface-induced crystallization of milk fat. | Curr Res Food Sci | 2024 | 39628600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2195/papers?page=15